Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore the dynamic landscape of therapeutic antibody development in this 43-minute webinar presented by Amanda Grimm, focusing on next-generation immuno-oncology therapeutics that target checkpoint inhibitors and incorporate immune system defense strategies to modulate T-cell engagers. Gain comprehensive insights into the history of antibody drugs, including key milestones and approved antibodies in immuno-oncology, while discovering how cutting-edge technologies can streamline workflows and optimize antibody leads. Learn about innovative solutions tailored to each stage of the therapeutic antibody development process, from preclinical studies through clinical trial transitions, with particular emphasis on GenScript's state-of-the-art technologies and expertise in advancing antibody drug discovery and development.
